Literature DB >> 26717121

Constructing Confidence Intervals for Effect Size Measures of an Indirect Effect.

Sunbok Lee1, Man Kit Lei1, Gene H Brody1.   

Abstract

Confidence intervals for an effect size can provide the information about the magnitude of an effect and its precision as well as the binary decision about the existence of an effect. In this study, the performances of five different methods for constructing confidence intervals for ratio effect size measures of an indirect effect were compared in terms of power, coverage rates, Type I error rates, and widths of confidence intervals. The five methods include the percentile bootstrap method, the bias-corrected and accelerated (BCa) bootstrap method, the delta method, the Fieller method, and the Monte Carlo method. The results were discussed with respect to the adequacy of the distributional assumptions and the nature of ratio quantity. The confidence intervals from the five methods showed similar results for samples of more than 500, whereas, for samples of less than 500, the confidence intervals were sufficiently narrow to convey the information about the population effect sizes only when the effect sizes of regression coefficients defining the indirect effect are large.

Keywords:  confidence intervals; effect sizes; indirect effects; mediation

Mesh:

Year:  2015        PMID: 26717121     DOI: 10.1080/00273171.2015.1040542

Source DB:  PubMed          Journal:  Multivariate Behav Res        ISSN: 0027-3171            Impact factor:   5.923


  2 in total

1.  Intervention effects on self-control decrease speed of biological aging mediated by changes in substance use: A longitudinal study of African American youth.

Authors:  Man-Kit Lei; Gene H Brody; Steven R H Beach
Journal:  Fam Process       Date:  2021-08-14

2.  The Impact of Harsh Parenting on the Development of Obesity in Adulthood: An Examination of Epigenetic/Gene Expression Mediators Among African American Youth.

Authors:  Man-Kit Lei; Steven R H Beach; Ronald L Simons; Kaixiong Ye
Journal:  Front Cardiovasc Med       Date:  2021-11-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.